Fresh Tracks Therapeutics Inc (FRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Sales | 486 | 4,315 | 92 | 104 | 132 |
| Gross Profit | 486 | 4,315 | 92 | 104 | 132 |
| Operating Expenses | 6,562 | 5,773 | 9,499 | 6,409 | 13,491 |
| Operating Income | -6,076 | -1,458 | -9,407 | -6,305 | -13,359 |
| Interest Expense | 0 | 2 | 4 | 4 | 1 |
| Other Income | 58 | 313 | 1 | 242 | 107 |
| Pre-tax Income | -6,018 | -1,147 | -9,410 | -6,067 | -13,253 |
| Net Income Continuous | -6,018 | -1,147 | -9,410 | -6,067 | -13,253 |
| Net Income | $-6,018 | $-1,147 | $-9,410 | $-6,067 | $-13,253 |
| EPS Basic Total Ops | -2.07 | -0.43 | -3.55 | -8.05 | -7.15 |
| EPS Basic Continuous Ops | -2.07 | -0.43 | -3.55 | -8.17 | -7.15 |
| EPS Diluted Total Ops | -2.07 | -0.43 | -3.55 | -8.05 | -7.15 |
| EPS Diluted Continuous Ops | -2.07 | -0.43 | -3.55 | -8.17 | -7.15 |
| EPS Diluted Before Non-Recurring Items | -2.07 | -0.01 | -3.60 | N/A | N/A |
| EBITDA(a) | $-6,068 | $-1,452 | $-9,400 | $-6,298 | $-13,352 |